Virologic's IPO

Virologic raised a round of funding on , . Investors include Public.

Virologic is a biotechnology company that performs, develops and markets drug susceptibility and resistance tests to be used in optimizing the treatment of patients with serious viral infections. Vir…

Articles about Virologic's IPO: